Concepedia

Marjan Kuijer

MK

12

Publications

479

Citations

11

H-Index

1992

Active since

Affiliations

National Institute for Public Health and the Environment(Current)

Leiden University Medical Center

Erasmus MC

Radboud University Medical Center

Radboud University Nijmegen

Marjan Kuijer is an author at National Institute for Public Health and the Environment specializing in medicine, immunology, and vaccinology.

ORCID

Top concepts

Publications per year

1992–2024

12

Publications

12

SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence

Gerco den Hartog, Rutger M. Schepp, Marjan Kuijer et al. · The Journal of Infectious Diseases · 2020 · 163 citations · Full text

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Frölke et al. · The Lancet Infectious Diseases · 2022 · 68 citations · Full text

, , +11

Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?

Lotus L. van den Hoogen, Gaby Smits, Cheyenne C. E. van Hagen et al. · Vaccine · 2022 · 67 citations · Full text

Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands

Lotus L. van den Hoogen, Mardi C. Boer, Abigail Postema et al. · Vaccines · 2022 · 33 citations · Full text

, , +21

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial

Margaretha Prins, Geert V.T. Roozen, Cilia R. Pothast et al. · npj Vaccines · 2024 · 30 citations · Full text

Rows per page

1–5 of 12